Interferon-alpha enhances the antitumour activity of EGFR-targeted therapies by upregulating RIG-I in head and neck squamous cell carcinoma
Interferon-alpha enhances the antitumour activity of EGFR-targeted therapies by upregulating RIG-I in head and neck squamous cell carcinoma, Published online: 18 January 2018; doi:10.1038/bjc.2017.442
Interferon-alpha enhances the antitumour activity of EGFR-targeted therapies by upregulating RIG-I in head and neck squamous cell carcinomahttp://ift.tt/2EUheYo
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου